Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells. (Q36622317)
Jump to navigation
Jump to search
scientific article published on June 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells. |
scientific article published on June 2001 |
Statements
Inhibition of protein farnesylation enhances the chemotherapeutic efficacy of the novel geranylgeranyltransferase inhibitor BAL9611 in human colon cancer cells (English)
S Caputo
M Macchia
M Lastella
U Boggi
F Mosca
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference